基本信息
浏览量:685
职业迁徙
个人简介
Hartmut Goldschmidt is Professor of Medicine (Hematology and Oncology) and Head of the Multiple Myeloma Program at the Medical Clinic V, Heidelberg University Hospital and National Center for Tumour Diseases (NCT) Heidelberg. Since 1998 Hartmut Goldschmidt coordinates the German-speaking Myeloma Multicenter Group (GMMG) conducting and participating in international phase Ⅱto Ⅲclinical trials according to GCP and evaluating hematopoietic stem cell transplantation and new compounds for multiple myeloma therapy. Hartmut Goldschmidt is an internationally renowned clinician and expert in the research of treatment, diagnosis and molecular biology of multiple myeloma and has published extensively on these topics. Translating the outcomes of clinical research into clinical practice immediately is of particular importance for him. Hartmut Goldschmidt is visiting Professor at the University of Belgrade.
研究兴趣
论文共 1094 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Leukemiano. 3 (2024): 640-647
European journal of nuclear medicine and molecular imagingpp.1-15, (2024)
Journal of Cancer Research and Clinical Oncologyno. 2 (2024): 1-9
The Lancet Haematologyno. 2 (2024): e101-e113
Blood advancesno. 2 (2024): 388-398
JOURNAL OF CLINICAL ONCOLOGYno. 1 (2024): 26-+
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERSpp.1-9, (2024)
Elias K Mai,Hartmut Goldschmid,Kaya Miah,Uta Bertsch, Britta Besemer,Mathias Hänel,Julia Krzykalla,Roland Fenk,Jana Schlenzka,Markus Munder, Jan Dürig, Igor W Blau,
The Lancet. Haematologyno. 2 (2024): e101-e113
Cancer Researchno. 6_Supplement (2024): 14-14
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn